In situ mapping of HSA reabsorption by a NIR fluorogenic sensor as a practical phenotypic assay for nephroprotective drug discovery
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.118490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Yufan Fan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China; State Key La…. Hauptthemen laut MEDLINE: Biosensing Techniques, Serum Albumin, Human, Protective Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Shanghai Lingjun Program, National Natural Science Foundation of China, National Science and Technology Major Project.
Abstract (Originalsprache)
The impaired reabsorption of kidney tubules is a critical early event in drug-induced kidney injury (DIKI), making real-time monitoring of human serum albumin (HSA) endocytosis essential for assessing renal function and screening nephroprotective agents. Inspired by the specific warfarin-HSA interactions, a novel coumarin-derived near-infrared (NIR) fluorogenic sensor, NCBP, was engineered based on a twisted intramolecular charge transfer (TICT) mechanism. Under physiological conditions, NCBP rapidly and stably bound to subdomain IIA of HSA with 1:1 stoichiometry, triggering a 79-fold fluorescence enhancement at 665 nm. NCBP integrated multiple advantages for detecting HSA, including instantaneous response, high physicochemical stability, ultrahigh sensitivity, and excellent selectivity. Furthermore, NCBP enabled in situ spatiotemporal imaging of HSA reabsorption in living nephrocytes and renal tissues, which was then used for screening nephroprotective agents to mitigate cisplatin-induced nephrotoxicity (CINT). Nobiletin (NOB) and 4',7-dimethoxyisoflavone (DIF) were identified as promising lead compounds capable of restoring renal uptake function and mitigating cisplatin-induced oxidative stress. In CINT mice, both NOB and DIF significantly improved renal function and attenuated tubular injury, confirming their nephroprotective potentials. Collectively, a TICT-based NIR sensor was developed for in situ imaging of HSA reabsorption, offering a robust phenotypic platform for spatiotemporal mapping of cellular HSA trafficking and discovering nephroprotective agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China; State Key Laboratory of Discovery and Utilization of Functional Components in Trad…
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine…
- Department of Pharmacy, Jingan District Zhabei Central Hospital, Shanghai, 200070, China.
- Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
- Department of Nephrology, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China. Electronic address: hujing@shutcm.edu.cn.
Förderung
- Shanghai Lingjun Program
- National Natural Science Foundation of China
- National Science and Technology Major Project
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
Zitieren
APA
Fan, Y., Zhao, B., Zhang, Y., Xie, P., Liu, L., Wang, X., Zhu, G., Guo, Z., Wang, F., Jin, Q., Hu, J., & Ge, G. (2026). In situ mapping of HSA reabsorption by a NIR fluorogenic sensor as a practical phenotypic assay for nephroprotective drug discovery. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.118490
Vancouver
Fan Y, Zhao B, Zhang Y, Xie P, Liu L, Wang X, et al. In situ mapping of HSA reabsorption by a NIR fluorogenic sensor as a practical phenotypic assay for nephroprotective drug discovery. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.118490
BibTeX
@article{Fan2026,
author = {Fan, Yufan and Zhao, Bei and Zhang, Ya and Xie, Pingjin and Liu, Lele and Wang, Xuerui and Zhu, Guanghao and Guo, Zhaobin and Wang, Fangyuan and Jin, Qiang and Hu, Jing and Ge, Guangbo},
title = {In situ mapping of HSA reabsorption by a NIR fluorogenic sensor as a practical phenotypic assay for nephroprotective drug discovery},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.118490}
}
EUVIMED